HEADER CELL CYCLE 21-OCT-20 7KHL TITLE BRD4-BD1 COMPOUND6 (METHYL 4-(3,5-DIFLUOROPYRIDIN-2-YL)-10-METHYL-7- TITLE 2 ((METHYLSULFONYL)METHYL)-11-OXO-3,4,10,11-TETRAHYDRO-1H-1,4,10- TITLE 3 TRIAZADIBENZO[CD,F]AZULENE-6-CARBOXYLATE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 4; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROTEIN HUNK1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD4, HUNK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET KEYWDS SBDD, CELL CYCLE EXPDTA X-RAY DIFFRACTION AUTHOR J.M.MURRAY REVDAT 3 18-OCT-23 7KHL 1 REMARK REVDAT 2 24-MAR-21 7KHL 1 JRNL REVDAT 1 24-FEB-21 7KHL 0 JRNL AUTH P.S.DRAGOVICH,T.H.PILLOW,R.A.BLAKE,J.D.SADOWSKY,E.ADALIGIL, JRNL AUTH 2 P.ADHIKARI,J.CHEN,N.CORR,J.DELA CRUZ-CHUH,G.DEL ROSARIO, JRNL AUTH 3 A.FULLERTON,S.J.HARTMAN,F.JIANG,S.KAUFMAN,T.KLEINHEINZ, JRNL AUTH 4 K.R.KOZAK,L.LIU,Y.LU,M.M.MULVIHILL,J.M.MURRAY,A.O'DONOHUE, JRNL AUTH 5 R.K.ROWNTREE,W.S.SAWYER,L.R.STABEN,J.WAI,J.WANG,B.WEI,W.WEI, JRNL AUTH 6 Z.XU,H.YAO,S.F.YU,D.ZHANG,H.ZHANG,S.ZHANG,Y.ZHAO,H.ZHOU, JRNL AUTH 7 X.ZHU JRNL TITL ANTIBODY-MEDIATED DELIVERY OF CHIMERIC BRD4 DEGRADERS. PART JRNL TITL 2 2: IMPROVEMENT OF IN VITRO ANTIPROLIFERATION ACTIVITY AND IN JRNL TITL 3 VIVO ANTITUMOR EFFICACY. JRNL REF J.MED.CHEM. V. 64 2576 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 33596073 JRNL DOI 10.1021/ACS.JMEDCHEM.0C01846 REMARK 2 REMARK 2 RESOLUTION. 1.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 52.46 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 74.3 REMARK 3 NUMBER OF REFLECTIONS : 48634 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.730 REMARK 3 FREE R VALUE TEST SET COUNT : 2300 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 51 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.29 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.33 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 14.23 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 973 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2587 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 917 REMARK 3 BIN R VALUE (WORKING SET) : 0.2551 REMARK 3 BIN FREE R VALUE : 0.3187 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.76 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 56 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2108 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 382 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.23 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.15 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.00560 REMARK 3 B22 (A**2) : -0.16770 REMARK 3 B33 (A**2) : -0.83790 REMARK 3 B12 (A**2) : 0.75980 REMARK 3 B13 (A**2) : -0.73810 REMARK 3 B23 (A**2) : -0.14620 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.190 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.076 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.077 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.071 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.074 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2301 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3160 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 813 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 395 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2247 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 292 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : 11 ; 1.000 ; HARMONIC REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2544 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.93 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.12 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.12 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -2.8585 10.4303 16.8377 REMARK 3 T TENSOR REMARK 3 T11: -0.0260 T22: -0.0372 REMARK 3 T33: -0.0510 T12: -0.0014 REMARK 3 T13: -0.0075 T23: 0.0043 REMARK 3 L TENSOR REMARK 3 L11: 1.5708 L22: 0.6391 REMARK 3 L33: 2.3432 L12: -0.4928 REMARK 3 L13: 1.3071 L23: -0.2888 REMARK 3 S TENSOR REMARK 3 S11: 0.1337 S12: 0.0857 S13: -0.0893 REMARK 3 S21: -0.0178 S22: -0.0787 S23: 0.0009 REMARK 3 S31: 0.1958 S32: 0.0804 S33: -0.0551 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 1.5656 31.2115 41.5732 REMARK 3 T TENSOR REMARK 3 T11: -0.0138 T22: -0.0345 REMARK 3 T33: -0.0430 T12: 0.0203 REMARK 3 T13: -0.0156 T23: -0.0137 REMARK 3 L TENSOR REMARK 3 L11: 0.8990 L22: 0.4551 REMARK 3 L33: 1.1190 L12: 0.0301 REMARK 3 L13: 0.1318 L23: 0.0152 REMARK 3 S TENSOR REMARK 3 S11: 0.0323 S12: -0.0239 S13: -0.0334 REMARK 3 S21: -0.0218 S22: -0.0547 S23: 0.0429 REMARK 3 S31: 0.0786 S32: -0.0245 S33: 0.0224 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS WERE FULLY REFINED WITH ZERO REMARK 3 OCCUPANCY AT NUCLEAR POSITION. REFINEMENT NOTES. NUMBER OF REMARK 3 REFINEMENT NOTES : 1 NOTE 1 : IDEAL-DIST CONTACT TERM CONTACT REMARK 3 SETUP. ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY REMARK 4 REMARK 4 7KHL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-OCT-20. REMARK 100 THE DEPOSITION ID IS D_1000252493. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-SEP-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0332 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 X 1M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51557 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.234 REMARK 200 RESOLUTION RANGE LOW (A) : 52.464 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 69.7 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.23 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.24 REMARK 200 COMPLETENESS FOR SHELL (%) : 8.2 REMARK 200 DATA REDUNDANCY IN SHELL : 1.80 REMARK 200 R MERGE FOR SHELL (I) : 1.78100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3MXF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14% W/V PEG 4K, 0.1 M TRIS-HCL PH 8, REMARK 280 PH 8.0, EVAPORATION, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 20 REMARK 465 HIS A 21 REMARK 465 HIS A 22 REMARK 465 HIS A 23 REMARK 465 HIS A 24 REMARK 465 HIS A 25 REMARK 465 HIS A 26 REMARK 465 SER A 27 REMARK 465 SER A 28 REMARK 465 GLY A 29 REMARK 465 VAL A 30 REMARK 465 ASP A 31 REMARK 465 LEU A 32 REMARK 465 GLY A 33 REMARK 465 THR A 34 REMARK 465 GLU A 35 REMARK 465 ASN A 36 REMARK 465 LEU A 37 REMARK 465 TYR A 38 REMARK 465 PHE A 39 REMARK 465 GLN A 40 REMARK 465 SER A 41 REMARK 465 GLU A 168 REMARK 465 MET B 20 REMARK 465 HIS B 21 REMARK 465 HIS B 22 REMARK 465 HIS B 23 REMARK 465 HIS B 24 REMARK 465 HIS B 25 REMARK 465 HIS B 26 REMARK 465 SER B 27 REMARK 465 SER B 28 REMARK 465 GLY B 29 REMARK 465 VAL B 30 REMARK 465 ASP B 31 REMARK 465 LEU B 32 REMARK 465 GLY B 33 REMARK 465 THR B 34 REMARK 465 GLU B 35 REMARK 465 ASN B 36 REMARK 465 LEU B 37 REMARK 465 TYR B 38 REMARK 465 PHE B 39 REMARK 465 GLN B 40 REMARK 465 GLU B 168 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue WEM A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 201 DBREF 7KHL A 44 168 UNP O60885 BRD4_HUMAN 44 168 DBREF 7KHL B 44 168 UNP O60885 BRD4_HUMAN 44 168 SEQADV 7KHL MET A 20 UNP O60885 INITIATING METHIONINE SEQADV 7KHL HIS A 21 UNP O60885 EXPRESSION TAG SEQADV 7KHL HIS A 22 UNP O60885 EXPRESSION TAG SEQADV 7KHL HIS A 23 UNP O60885 EXPRESSION TAG SEQADV 7KHL HIS A 24 UNP O60885 EXPRESSION TAG SEQADV 7KHL HIS A 25 UNP O60885 EXPRESSION TAG SEQADV 7KHL HIS A 26 UNP O60885 EXPRESSION TAG SEQADV 7KHL SER A 27 UNP O60885 EXPRESSION TAG SEQADV 7KHL SER A 28 UNP O60885 EXPRESSION TAG SEQADV 7KHL GLY A 29 UNP O60885 EXPRESSION TAG SEQADV 7KHL VAL A 30 UNP O60885 EXPRESSION TAG SEQADV 7KHL ASP A 31 UNP O60885 EXPRESSION TAG SEQADV 7KHL LEU A 32 UNP O60885 EXPRESSION TAG SEQADV 7KHL GLY A 33 UNP O60885 EXPRESSION TAG SEQADV 7KHL THR A 34 UNP O60885 EXPRESSION TAG SEQADV 7KHL GLU A 35 UNP O60885 EXPRESSION TAG SEQADV 7KHL ASN A 36 UNP O60885 EXPRESSION TAG SEQADV 7KHL LEU A 37 UNP O60885 EXPRESSION TAG SEQADV 7KHL TYR A 38 UNP O60885 EXPRESSION TAG SEQADV 7KHL PHE A 39 UNP O60885 EXPRESSION TAG SEQADV 7KHL GLN A 40 UNP O60885 EXPRESSION TAG SEQADV 7KHL SER A 41 UNP O60885 EXPRESSION TAG SEQADV 7KHL ASN A 42 UNP O60885 EXPRESSION TAG SEQADV 7KHL ALA A 43 UNP O60885 EXPRESSION TAG SEQADV 7KHL MET B 20 UNP O60885 INITIATING METHIONINE SEQADV 7KHL HIS B 21 UNP O60885 EXPRESSION TAG SEQADV 7KHL HIS B 22 UNP O60885 EXPRESSION TAG SEQADV 7KHL HIS B 23 UNP O60885 EXPRESSION TAG SEQADV 7KHL HIS B 24 UNP O60885 EXPRESSION TAG SEQADV 7KHL HIS B 25 UNP O60885 EXPRESSION TAG SEQADV 7KHL HIS B 26 UNP O60885 EXPRESSION TAG SEQADV 7KHL SER B 27 UNP O60885 EXPRESSION TAG SEQADV 7KHL SER B 28 UNP O60885 EXPRESSION TAG SEQADV 7KHL GLY B 29 UNP O60885 EXPRESSION TAG SEQADV 7KHL VAL B 30 UNP O60885 EXPRESSION TAG SEQADV 7KHL ASP B 31 UNP O60885 EXPRESSION TAG SEQADV 7KHL LEU B 32 UNP O60885 EXPRESSION TAG SEQADV 7KHL GLY B 33 UNP O60885 EXPRESSION TAG SEQADV 7KHL THR B 34 UNP O60885 EXPRESSION TAG SEQADV 7KHL GLU B 35 UNP O60885 EXPRESSION TAG SEQADV 7KHL ASN B 36 UNP O60885 EXPRESSION TAG SEQADV 7KHL LEU B 37 UNP O60885 EXPRESSION TAG SEQADV 7KHL TYR B 38 UNP O60885 EXPRESSION TAG SEQADV 7KHL PHE B 39 UNP O60885 EXPRESSION TAG SEQADV 7KHL GLN B 40 UNP O60885 EXPRESSION TAG SEQADV 7KHL SER B 41 UNP O60885 EXPRESSION TAG SEQADV 7KHL ASN B 42 UNP O60885 EXPRESSION TAG SEQADV 7KHL ALA B 43 UNP O60885 EXPRESSION TAG SEQRES 1 A 149 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 149 GLY THR GLU ASN LEU TYR PHE GLN SER ASN ALA ASN PRO SEQRES 3 A 149 PRO PRO PRO GLU THR SER ASN PRO ASN LYS PRO LYS ARG SEQRES 4 A 149 GLN THR ASN GLN LEU GLN TYR LEU LEU ARG VAL VAL LEU SEQRES 5 A 149 LYS THR LEU TRP LYS HIS GLN PHE ALA TRP PRO PHE GLN SEQRES 6 A 149 GLN PRO VAL ASP ALA VAL LYS LEU ASN LEU PRO ASP TYR SEQRES 7 A 149 TYR LYS ILE ILE LYS THR PRO MET ASP MET GLY THR ILE SEQRES 8 A 149 LYS LYS ARG LEU GLU ASN ASN TYR TYR TRP ASN ALA GLN SEQRES 9 A 149 GLU CYS ILE GLN ASP PHE ASN THR MET PHE THR ASN CYS SEQRES 10 A 149 TYR ILE TYR ASN LYS PRO GLY ASP ASP ILE VAL LEU MET SEQRES 11 A 149 ALA GLU ALA LEU GLU LYS LEU PHE LEU GLN LYS ILE ASN SEQRES 12 A 149 GLU LEU PRO THR GLU GLU SEQRES 1 B 149 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 B 149 GLY THR GLU ASN LEU TYR PHE GLN SER ASN ALA ASN PRO SEQRES 3 B 149 PRO PRO PRO GLU THR SER ASN PRO ASN LYS PRO LYS ARG SEQRES 4 B 149 GLN THR ASN GLN LEU GLN TYR LEU LEU ARG VAL VAL LEU SEQRES 5 B 149 LYS THR LEU TRP LYS HIS GLN PHE ALA TRP PRO PHE GLN SEQRES 6 B 149 GLN PRO VAL ASP ALA VAL LYS LEU ASN LEU PRO ASP TYR SEQRES 7 B 149 TYR LYS ILE ILE LYS THR PRO MET ASP MET GLY THR ILE SEQRES 8 B 149 LYS LYS ARG LEU GLU ASN ASN TYR TYR TRP ASN ALA GLN SEQRES 9 B 149 GLU CYS ILE GLN ASP PHE ASN THR MET PHE THR ASN CYS SEQRES 10 B 149 TYR ILE TYR ASN LYS PRO GLY ASP ASP ILE VAL LEU MET SEQRES 11 B 149 ALA GLU ALA LEU GLU LYS LEU PHE LEU GLN LYS ILE ASN SEQRES 12 B 149 GLU LEU PRO THR GLU GLU HET WEM A 201 37 HET GOL B 201 14 HETNAM WEM METHYL 7-(3,5-DIFLUOROPYRIDIN-2-YL)-2-METHYL-10- HETNAM 2 WEM [(METHYLSULFONYL)METHYL]-3-OXO-3,4,6,7-TETRAHYDRO-2H- HETNAM 3 WEM 2,4,7-TRIAZADIBENZO[CD,F]AZULENE-9-CARBOXYLATE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 WEM C24 H20 F2 N4 O5 S FORMUL 4 GOL C3 H8 O3 FORMUL 5 HOH *382(H2 O) HELIX 1 AA1 THR A 60 VAL A 69 1 10 HELIX 2 AA2 VAL A 69 HIS A 77 1 9 HELIX 3 AA3 ALA A 80 GLN A 84 5 5 HELIX 4 AA4 ASP A 96 ILE A 101 1 6 HELIX 5 AA5 ASP A 106 ASN A 116 1 11 HELIX 6 AA6 ASN A 121 ASN A 140 1 20 HELIX 7 AA7 ASP A 144 ASN A 162 1 19 HELIX 8 AA8 THR B 60 VAL B 69 1 10 HELIX 9 AA9 VAL B 69 LYS B 76 1 8 HELIX 10 AB1 HIS B 77 GLN B 84 5 8 HELIX 11 AB2 ASP B 96 ILE B 101 1 6 HELIX 12 AB3 ASP B 106 ASN B 116 1 11 HELIX 13 AB4 ASN B 121 ASN B 140 1 20 HELIX 14 AB5 ASP B 144 ASN B 162 1 19 SITE 1 AC1 18 TRP A 81 PRO A 82 PHE A 83 GLN A 85 SITE 2 AC1 18 PRO A 86 VAL A 87 ASP A 88 LEU A 92 SITE 3 AC1 18 ASN A 140 ASP A 145 ILE A 146 MET A 149 SITE 4 AC1 18 HOH A 311 HOH A 322 HOH A 403 HIS B 77 SITE 5 AC1 18 ALA B 152 LEU B 156 SITE 1 AC2 5 LEU B 92 LEU B 94 ASN B 140 HOH B 319 SITE 2 AC2 5 HOH B 325 CRYST1 30.278 41.812 54.256 84.58 76.30 89.92 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.033027 -0.000046 -0.008085 0.00000 SCALE2 0.000000 0.023917 -0.002328 0.00000 SCALE3 0.000000 0.000000 0.019061 0.00000